Literature DB >> 22382866

Enhanced recovery from respiratory infection following treatment with a PDE-5 inhibitor: a single case study.

Andrew J Ashworth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382866      PMCID: PMC6547895          DOI: 10.4104/pcrj.2012.00016

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


× No keyword cloud information.
  5 in total

1.  The idolatry of the surrogate.

Authors:  John S Yudkin; Kasia J Lipska; Victor M Montori
Journal:  BMJ       Date:  2011-12-28

2.  Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.

Authors:  C H Compton; J Gubb; R Nieman; J Edelson; O Amit; A Bakst; J G Ayres; J P Creemers; G Schultze-Werninghaus; C Brambilla; N C Barnes
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

Review 3.  The use of roflumilast in COPD: a primary care perspective.

Authors:  David Price; Alison Chisholm; Dermot Ryan; Alan Crockett; Rupert Jones
Journal:  Prim Care Respir J       Date:  2010-12

Review 4.  Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations.

Authors:  Ioanna Tsiligianni; Janwillem Kocks; Nikolaos Tzanakis; Nikolaos Siafakas; Thys van der Molen
Journal:  Prim Care Respir J       Date:  2011-09

Review 5.  Functional status measurement in COPD: a review of available methods and their feasibility in primary care.

Authors:  Janwillem W H Kocks; Guus M Asijee; Ioanna G Tsiligianni; Huib A M Kerstjens; Thys van der Molen
Journal:  Prim Care Respir J       Date:  2011-09
  5 in total
  1 in total

1.  No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19.

Authors:  Moshe Rogosnitzky; Esther Berkowitz; Alejandro R Jadad
Journal:  JMIRx Med       Date:  2020-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.